Stocks · News reference
Market-Moving News for August 25th
AMIX: 126% | Autonomix Medical shares are trading higher ahead of the Patent and Trademark Office's decision to grant the company U.S. Patent No. 12,714,780 titled "Systems and Methods for Regulating Organ
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Surrozen Says FDA Cleared IND For SZN-8141 In Diabetic Macular Edema, Triggering About $95.1M Second Tranche Of Private Placement
Autonomix Medical Completes Pre-Submission Meeting With FDA For Its Transvascular Sensing Platform
Autonomix Medical Receives European Patent Titled Systems For Assessing Neural Activity In An Eye
Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the grant of European Patent
Shares of software companies are trading lower amid a broader technology sell-off led by declines in Micron and other semiconductor stocks. Comments from Intel and Broadcom CEOs that limited access to capital could constrain AI expansion, despite strong demand for computing infrastructure, are adding to concerns about the sustainability of tech-sector growth.
Gorilla Technology Group shares are trading lower. The company announced that it has entered into a non-binding letter of intent in connection with the proposed acquisition of its first data center in the United States.